Insights

Medicines and medical devices regulation post-Brexit

Data exclusivity for innovators - a bridge too far?

The EU-US Privacy Shield: getting your certification ready

Reservation deposits and new build properties

The role of the Consumer Code for Homebuilders

First UK company to be liable for modern slavery

Access to medicines in developing countries – what likely impact will GSK’s move have?

CJEU confirms orphan drug market exclusivity

Biosimilars and the issue of duplicates

Intellectual Property in the Life Sciences, in review

Setting the record straight - employee background checks

Three recent cases concerning early conciliation

Fundamental changes to insurance contract law: The Insurance Act 2015